A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma
Open Access
- 1 December 2000
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 83 (12), 1623-1629
- https://doi.org/10.1054/bjoc.2000.1498
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapyEuropean Journal Of Cancer, 1997
- Radiotherapy after chemotherapy for metastatic seminoma—a diminishing roleEuropean Journal Of Cancer, 1997
- Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.Journal of Clinical Oncology, 1997
- Current status of chemotherapy in advanced seminomaEuropean Journal Of Cancer, 1997
- Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy?International Journal of Radiation Oncology*Biology*Physics, 1994
- Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.Journal of Clinical Oncology, 1993
- SINGLE-AGENT TREATMENT OF ADVANCED SEMINOMA WITH CARBOPLATIN IN OUTPATIENTS1990
- Advanced Seminoma: The Role of Chemotherapy and Adjunctive SurgeryAnnals of Internal Medicine, 1988
- COMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTISThe Lancet, 1979
- Combination chemotherapy in germinal cell tumorsCancer Treatment Reviews, 1976